טוען...
Should young children with sickle cell disease and an available human leukocyte antigen identical sibling donor be offered hematopoietic cell transplantation?
Availability of an HLA-identical sibling donor raises the question, “should young children with SCD, and an available HLA identical sibling donor be considered for hematopoietic cell transplantation (HCT) even before they manifest severe clinical presentations of sickle cell disease (SCD)?” The over...
שמור ב:
| מחבר ראשי: | |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2020-06-01
|
| סדרה: | Hematology/Oncology and Stem Cell Therapy |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S1658387620300273 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|